Perrigo Buys Prevacid U.S. OTC Rights From GlaxoSmithKline
05 September 2019 - 11:24PM
Dow Jones News
By Chris Wack
Perrigo Company Plc (PRGO) said Thursday it is buying the
branded over-the-counter rights to Prevacid from GlaxoSmithKline
(GSK).
Perrigo said under the terms of the agreement, it will have the
exclusive rights to market, sell and distribute Prevacid 24HR in
the U.S. OTC market.
Financial terms of the agreement weren't disclosed.
Prevacid 24HR treats frequent heartburn occurring two or more
days a week.
Write to Chris Wack at chris.wack@wsj.com
(END) Dow Jones Newswires
September 05, 2019 09:09 ET (13:09 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
GSK (NYSE:GSK)
Historical Stock Chart
From Apr 2024 to May 2024
GSK (NYSE:GSK)
Historical Stock Chart
From May 2023 to May 2024